MT3 and arthritic joint disease: Additionally, the MT3 + CFA group, treated with either 1 or 10 mg/kg TPEN, demonstrated a notable increase in arthritis scores compared to scores in the MT3 WT + CFA group in a TPEN concentration-dependent manner (Fig. 2C).